Currently, common clinical GLP-1RAs include exenatide and exenatide-LAR [34,35,36,37,38,39,40], lixisenatide [41,42,43,44], beinaglutide [45], liraglutide [46,47,48,49,50,51,52,53], semaglutide [54,55,56,57,58], albiglutide [59,60,61], dulaglutide [62,63,64], oral semaglutide [58, 65,66,67], PEG-loxenatide [68] and tirzepatide [68,69,70,71,72,73] (Table 1)
Comparative studies against GHRP-6 and GHRP-2 showed equivalent GH release with substantially superior hormonal selectivity, establishing Ipamorelin's mechanism through the ghrelin receptor and its pulsatile GH release profile
Unexpectedly, we also observed telomere length increase in two telomerase-positive cancer cell lines however, this was found to occur through ALT activation
How many units is 2.5 mg of tirzepatide